Faecal Analyses in Rheumatoid Arthritis Therapy

计划入组 50 人 · 首次发布于 2018 年 12 月 14 日

START

计划入组 2,300 人

Strategic Timing of AntiRetroviral Treatment(START) - START

计划入组 216 人

4D-110

NFS-02

Firolimogene autotemcel

Smart Start L.L.C.

United States

SOUTHCENTRAL FOUNDATION

United States

CHARLES R DREW UNIVERSITY OF MEDICINE AND SCIENCE

United States

Semarion Secures $3.8M to Scale Cell-Based Drug Discovery Platform

TRIMTECH Therapeutics Secures $31M Seed Funding for Novel Protein Degradation Platform Targeting Neurodegenerative Diseases

HotHouse Therapeutics Emerges with £2.9M to Revolutionize Plant-Based Drug Manufacturing Using AI